Bob currently serves as a Director at Beam Therapeutics where he leads the automation, robotics, and next generation sequencing (NGS) teams supporting cutting edge base editing research. At Beam Therapeutics, Bob has led the implementation of industry leading lab automation, designed cloud-first lab informatics solutions, and led the formation of a centralized Next Generation Sequencing Core. Prior to Beam, Bob held many leadership roles at Dow AgroSciences including In Vivo Platform Leader for the Predictive Safety Center and R&D AP Testing Leader. Prior to Dow, Bob worked as a forensic scientist specializing in human identification at Strand Analytical Laboratories and LabCorp. Bob has an MS in biotechnology from The Johns Hopkins University and a BS in molecular and cellular biology from the University of Illinois Urbana-Champaign.